Fed's Patience Puts Bulls In A Hurry
Scott Martindale - Seeking Alpha - Tue Dec 23, 11:08AM CST
U.S. stocks found support once again last week and rallied on strong volume. Of course, the main catalyst was the FOMC policy statement on Wednesday that maintained its dovish language with a pledge of considerable time before raising the fed funds...
DEF: 38.15 (-0.96), NFO: 49.34 (-0.38), PNW: 69.59 (+1.41), UTHR: 130.22 (+2.40), ED: 66.91 (+0.90), IBB: 299.80 (+5.12), LUV: 41.66 (+0.68), IYZ: 29.52 (-0.18), LYB: 81.31 (-0.89), SPY: 207.77 (+0.02), IDU: 120.07 (+1.13), IYW: 106.52 (-0.41), IYK: 106.07 (-0.66), IYJ: 108.21 (-0.61), IYH: 144.69 (+0.58), BCR: 169.10 (-0.44), IYM: 83.15 (-0.74), IYC: 137.57 (-0.15), NXPI: 76.75 (+0.48), FUTY: 31.00 (+0.60), IYF: 91.09 (-0.41), IYE: 45.37 (-0.54), PYZ: 53.07 (+0.10), SHW: 264.55 (+1.46), KNOW: 69.79 (+0.15)
CR Bard Has Returned 16.2% Since SmarTrend Recommendation (BCR)
Comtex SmarTrend(R) - Fri Dec 19, 9:23AM CST
SmarTrend identified an Uptrend for CR Bard (NYSE:BCR) on October 6th, 2014 at $148.49. In approximately 2 months, CR Bard has returned 16.18% as of today's recent price of $172.51.
BCR: 169.10 (-0.44)
AngioDynamics (ANGO) Hits 52-Week High on Positive View - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Dec 18, 2:37PM CST
Shares of AngioDynamics Inc (ANGO) reached a 52-week high of $19.20 on Dec 17, 2014.
BSX: 13.13 (+0.07), BCR: 169.10 (-0.44), ANGO: 19.19 (+0.33), MMSI: 17.17 (+0.01)
CR Bard Strong on Acquisitions, FDA Nod for Lutonix DCB - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Dec 17, 3:55PM CST
CR Bard's initiative to introduce its products in the emerging markets is delivering accretive returns, as the company continues with its sturdy performance in the international markets.
BSX: 13.13 (+0.07), JNJ: 104.59 (+0.31), BCR: 169.10 (-0.44), ANGO: 19.19 (+0.33)
CR Bard (BCR) Faces Series of Lawuits - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 16, 4:25PM CST
CR Bard Inc. (BCR) has been hit by a wave of product liability lawsuits over its faulty pelvic mesh products and defective vaginal-mesh implants, which could result in billions of dollars in damages.
BSX: 13.13 (+0.07), JNJ: 104.59 (+0.31), ENDP: 72.10 (+0.34), BCR: 169.10 (-0.44)
Jim Cramer: These Charts Prove It's Oil-and-Gas vs. Everything Else
at The Street - Tue Dec 16, 10:01AM CST
Reams of stocks make sense on a pullback. And what looks bad? Anything even remotely connected to oil and gas.
CAH: 82.07 (+0.15), WMT: 86.43 (-0.23), PDCO: 48.79 (-0.02), JACK: 78.82 (-0.17), CFR: 70.74 (+0.17), RCL: 82.36 (+0.16), TGT: 74.65 (-0.04), LOW: 67.51 (-0.43), MSFT: 48.14 (-0.31), HSIC: 137.87 (+0.15), REGN: 400.12 (+6.07), YUM: 72.79 (+0.11), SYK: 96.00 (-0.61), MU: 34.91 (-0.06), BCR: 169.10 (-0.44), MCK: 209.79 (+0.58), STX: 68.82 (+0.17), EW: 130.75 (+1.17), WLP: 128.71 (+0.94), UAL: 64.93 (+2.45), CELG: 109.60 (+3.48), CBRL: 138.16 (+0.46), AZO: 617.43 (-3.87), STE: 66.76 (+0.85), MRK: 57.46 (+0.25), MCD: 93.83 (-0.39), SHW: 264.55 (+1.46), BIIB: 340.89 (+5.13), BDX: 139.90 (+1.44), BMRN: 88.18 (+0.89), CCL: 45.39 (+0.09), MDT: 74.08 (+0.31), SNA: 139.09 (unch), JBLU: 15.50 (+0.21), ADBE: 74.74 (+0.36), HUM: 144.38 (-0.31), RFMD: 16.59 (+0.29), EBAY: 57.10 (-0.12), DPZ: 95.39 (-0.23), SRCL: 133.27 (-0.16), XLF: 24.95 (-0.04), ZMH: 114.11 (+0.64), CY: 14.61 (+0.26), HD: 103.56 (-0.20), ORLY: 193.95 (-1.11), DIS: 94.42 (-0.27), LLY: 70.16 (+0.42), BMY: 59.15 (-0.01), WDC: 113.11 (-0.18), PLKI: 55.50 (+0.01), HPQ: 40.54 (+0.18), FRGI: 56.97 (+0.47), DIN: 101.87 (-0.40), DRI: 58.42 (-0.09), CI: 104.23 (-0.08), ABC: 91.60 (+0.18), TJX: 67.87 (-0.25), JWN: 78.14 (-0.58), AVGO: 100.72 (-0.06)
The Best Of The Best: Top 7 Dividend Aristocrats
Sure Dividend - at Seeking Alpha - Mon Dec 15, 6:55PM CST
Over the past 3 months I have analyzed each of the 54 Dividend Aristocrats. The complete list of Dividend Aristocrats sorted by sector is included in the tables below: Basic Materials Consumer Goods Financials Health Care ...
MKC: 76.63 (-0.15), GPC: 107.62 (-0.21), CAH: 82.07 (+0.15), ED: 66.91 (+0.90), SYY: 40.59 (-0.11), WMT: 86.43 (-0.23), GWW: 256.98 (-0.82), PNR: 66.99 (-0.09), TGT: 74.65 (-0.04), ABBV: 66.21 (+1.86), LOW: 67.51 (-0.43), BCR: 169.10 (-0.44), TROW: 87.34 (-0.25), VFC: 74.63 (-0.01), FDO: 79.14 (-0.01), HRL: 53.08 (-0.17), MHFI: 90.70 (+0.34), ADP: 85.24 (+0.07), ADM: 53.11 (-0.06), SIAL: 137.16 (-0.01), MCD: 93.83 (-0.39), DOV: 74.20 (-0.28), CVX: 113.47 (-0.48), SHW: 264.55 (+1.46), BF.B: 90.41 (+0.40), MMM: 166.96 (+0.09), BDX: 139.90 (+1.44), CLX: 105.46 (-0.62), MDT: 74.08 (+0.31), KMB: 117.77 (-0.21), XOM: 93.78 (-0.81), CB: 104.37 (-0.07), PEP: 97.09 (-0.27), SWK: 97.36 (+0.04), JNJ: 104.59 (+0.31), T: 33.96 (-0.07), CINF: 52.18 (-0.19), PPG: 231.12 (+0.05), WAG: 76.67 (+0.16), APD: 148.58 (unch), ECL: 107.18 (-0.27), KO: 42.94 (-0.03), ABT: 45.70 (-0.02), HCP: 44.00 (-0.45), NUE: 49.33 (-0.22), EMR: 62.73 (-0.10), LEG: 42.40 (+0.19), BMS: 45.96 (-0.12), ITW: 97.11 (-0.10), CTAS: 79.86 (+0.22), PG: 93.14 (-0.15), BEN: 56.99 (-0.14), AFL: 61.94 (unch), CL: 70.47 (-0.53)
Dividend Aristocrat Overview: C. R. Bard, Inc.
Harvesting Dividends - at Seeking Alpha - Fri Dec 12, 8:01PM CST
About C. R. Bard C. R. Bard (NYSE: BCR ), headquartered in Murray Hill, New Jersey, develops medical technologies and medical devices for that helps patients manage a variety of diseases. The company had sales in 2013 of $3.05 billion, up 3.1%...
BCR: 169.10 (-0.44)
Judge advises Bard to settle mesh lawsuits
Seeking Alpha - at Seeking Alpha - Fri Dec 12, 7:14AM CST
BSX: 13.13 (+0.07), JNJ: 104.59 (+0.31), BCR: 169.10 (-0.44)
Global Cardiology Surgical & Interventional Cardiology Devices Market 2014-2020
M2 - Fri Dec 12, 2:33AM CST
Research and Markets (http://www.researchandmarkets.com/research/kddzlk/cardiology) has announced the addition of the "Cardiology Surgical & Interventional Cardiology Devices Market - 2014-2020" report to their offering. The global market of cardiovascular surgical devices is expected to grow at CAGR of 9% from 2014 to 2020. The cardiovascular surgical devices market includes wide range of diagnostic and therapeutic devices which are used in surgery such as Imaging devices, cardiovascular stents, catheter, cardiac rhythm management devices, monitoring devices and conventional surgical tools. There are different types of cardiovascular surgeries for which different surgical approaches and devices are required. This report includes Coronary Artery Bypass Grafting (CABG), Transmyocardial Laser Revascularization (TMR), Heart Valve Repair or Replacement, Arrhythmia Treatment, Aneurysm Repair, Heart Transplant and Surgery to Place Ventricular Assist Devices or Total Artificial Hearts. Surgical approaches for these surgeries are Open-Heart Surgery, Off-Pump Heart Surgery and Minimally Invasive Heart Surgery. US is the largest market for the cardiovascular surgery devices with 46% of global share. Europe has captured 27% of market share in the cardiovascular surgery devices. APAC has largest growth in the market which mainly comes from China and Japan. Key Topics Covered: 1. Executive summery 2. Cardiac surgical devices market overview 3. Market determinants 4. Market segmentation 5. Cost analysis 6. Market strategies 7. Market share 8. Geography analysis 9. Patent Analysis 10. Corporate profiles - Abbott Cardiovascular - Boston Scientific Corp. - C.R. Bard, Inc. - Cook Medical - Medtronic. Inc - Toshiba Corp - Covidien - Biosense Webster, Inc. - Edwards Lifescience Corp. - Plc Medical Systems For more information visit http://www.researchandmarkets.com/research/kddzlk/cardiology
BSX: 13.13 (+0.07), BCR: 169.10 (-0.44), MDT: 74.08 (+0.31), MDSY: 3.35 (-0.05)
AngioDynamics (ANGO) Signs PICC Deal with HealthTrust - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Dec 11, 3:50PM CST
AngioDynamics Inc. (ANGO) has entered into a strategic partnership with HealthTrust, covering AngioDynamics' PICC (peripherally inserted central catheter) products.
BCR: 169.10 (-0.44), VASC: 27.30 (+0.71), ANGO: 19.19 (+0.33), MMSI: 17.17 (+0.01)
C. R. Bard declares $0.22 dividend
Seeking Alpha - at Seeking Alpha - Wed Dec 10, 3:23PM CST
BCR: 169.10 (-0.44)
Bard Declares Quarterly Dividend
Business Wire - Wed Dec 10, 3:05PM CST
The Board of Directors of C. R. Bard, Inc. (NYSE:BCR) today declared a regular quarterly dividend of 22 cents per share on Bard's common stock. The current indicated annual dividend rate is 88 cents per share. The dividend is payable on February 6, 2015 to shareholders of record at the close of business on January 26, 2015.
BCR: 169.10 (-0.44)
CR Bard Up 14.1% Since SmarTrend Uptrend Call (BCR)
Comtex SmarTrend(R) - Wed Dec 10, 11:19AM CST
SmarTrend identified an Uptrend for CR Bard (NYSE:BCR) on October 6th, 2014 at $148.49. In approximately 2 months, CR Bard has returned 14.12% as of today's recent price of $169.46.
BCR: 169.10 (-0.44)
Allergan Leads The 20 Best Value Bond Trades With A Maturity Of 1 Year Or More
Donald van Deventer - at Seeking Alpha - Wed Dec 10, 11:17AM CST
BDX: 139.90 (+1.44), BCR: 169.10 (-0.44), AXP: 94.08 (+0.26), TMO: 126.79 (+0.13), WBK: 26.85 (+0.22), AMT: 100.75 (+0.10), C: 54.54 (+0.12), AMGN: 160.67 (+3.15), CELG: 109.60 (+3.48), MCO: 98.29 (+0.29), AGN: 210.12 (+0.95), T: 33.96 (-0.07), GS: 195.89 (+0.39), JPM: 62.48 (unch), GILD: 91.29 (+1.84), MMP: 85.74 (+0.15)
Becton, Dickinson-Aethon to Boost Medication Management - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 09, 5:50PM CST
Per the deal, the integrated solution will combine Becton Dickinson and Company's (BDX) leading-edge BD Cato IV Workflow product with Aethon's MedEx medication delivery tracking system.
ABC: 91.60 (+0.18), BDX: 139.90 (+1.44), BCR: 169.10 (-0.44), MMSI: 17.17 (+0.01)
CR Bard Set to Possibly Rebound After Yesterday's Selloff of 1.49%
Comtex SmarTrend(R) - Tue Dec 09, 4:39PM CST
CR Bard (NYSE:BCR) traded in a range yesterday that spanned from a low of $169.82 to a high of $171.53. Yesterday, the shares fell 1.5%, which took the trading range below the 3-day low of $171.44 on volume of 718,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
BCR: 169.10 (-0.44)
SmarTrend Watching for Potential Rebound in Shares of CR Bard After 1.49% Loss
Comtex SmarTrend(R) - Tue Dec 09, 4:38PM CST
CR Bard (NYSE:BCR) traded in a range yesterday that spanned from a low of $169.82 to a high of $171.53. Yesterday, the shares fell 1.5%, which took the trading range below the 3-day low of $171.44 on volume of 718,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
BCR: 169.10 (-0.44)
The Cooper Companies Q4 Earnings, Revenues Lag; Up Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Dec 05, 3:09PM CST
The Cooper Companies Inc (COO) reported fourth-quarter 2014 earnings of $1.95 per share, which missed the Zacks Consensus Estimates by 8 cents.
ABC: 91.60 (+0.18), BCR: 169.10 (-0.44), MMSI: 17.17 (+0.01), COO: 164.19 (+0.99)
Teleflex Partners with Premier to Expand Dialysis Portfolio - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Dec 03, 4:50PM CST
Teleflex Inc (TFX), recently entered into a strategic partnership with Premier, Inc., a healthcare solutions organization, for the former's ARROW Dialysis Access portfolio.
BCR: 169.10 (-0.44), CFN: 59.18 (+0.04), COV: 103.35 (+0.57), TFX: 116.82 (+0.28)